Shire - Messenger RNA Platform's Unit Acquisition

Shire - Messenger RNA Platform raised a round of funding on January 04, 2017. Investors include Translate Bio.

Shire (NASDAQ: SHPG) is a global biotechnology company that focuses on developing and delivering treatments for patients with rare diseases and other specialty conditions.…

Articles about Shire - Messenger RNA Platform's Unit Acquisition: